My da|ra Login

Detailed view

metadata language: English

Evaluation of Adult Urine Testing/Drug Use Surveillance Project in Washington, DC, 1984-1986

Version
v1
Resource Type
Dataset : administrative records data, survey data, and clinical data
Creator
  • Toborg, Mary (Toborg Associates, Inc., Washington, DC)
  • Yezer, Anthony (Toborg Associates, Inc., Washington, DC)
  • Bellassai, John (Toborg Associates, Inc., Washington, DC)
Other Title
  • Version 1 (Subtitle)
Publication Date
1993-05-13
Funding Reference
  • United States Department of Justice. Office of Justice Programs. National Institute of Justice
Language
English
Free Keywords
drug testing; drug treatment; drug use; pretrial procedures; recidivism; substance abuse; urinalysis
Description
  • Abstract

    These data were gathered to assess whether drug users are greater risks than nonusers for rearrest or failure to appear for scheduled court appearances while on pretrial release. The data also evaluate the relative effectiveness of periodic surveillance through urinalysis, traditional narcotic treatment, or neither in reducing rearrest and failure to appear during the pretrial period. The collection provides information on arrestees who both tested positive for drugs and were released on recognizance as well as those arrestees who tested negative but were not released on recognizance. Drugs tested for include heroin, cocaine, PCP, methadone, and amphetamines. Arrestees who were released were randomly assigned to one of three groups: weekly urine testing, referral to drug treatment, or a control condition. The data offer information on the offender's background, family and employment status, probation and parole status, pending charges, and prior convictions. Other variables include date of arrest, charge, initial release, decision, date of disposition, type of final disposition, number of subsequent arrests before trial, and number of bench warrants issued. Results of urine tests at arrest are available for about 65 percent of the total sample. For those in the experimental surveillance group, summary urine test results from the periodic testing program are available. There is no measure of treatment for the drug treatment or control groups.
  • Abstract

    Data were collected for two purposes: (1) to assess whether drug users are greater risks than nonusers for rearrest or failure to appear (FTA) for scheduled court appearances while on pretrial release, and (2) to test the relative effectiveness of periodic surveillance through urinalysis, traditional narcotic treatment, or neither in reducing rearrest and FTA during the pretrial period. The Pretrial Services Agency (PSA) of Washington, DC tests arrestees for drug use at the time of arrest. The data include urine test results for five drugs: heroin, cocaine, PCP, methadone, and amphetamines. An important feature of this study is that persons who (1) tested positive for drugs and (2) who were released on recognizance were randomly assigned to one of three groups: periodic urine testing (usually weekly), referral to drug treatment, or a control condition. The data file also includes arrestees who were negative for drugs and for whom a Released on Recognizance (ROR) release was not obtained.
  • Abstract

    The PSA collects information relevant for pretrial release recommendations including offender's background, family and employment status, probation and parole status, pending charges, and prior convictions. The data also contain the PSA's summary assessment of likely offender flight or safety problems and the reasons for that assessment. The official record information includes date of arrest, charge, initial release decision, date of disposition, type of final disposition, number of subsequent arrests before trial, date of first rearrest, FTA information, and number of bench warrants issued. Results of urine tests at arrest are available for about 65 percent of the total sample. For those in the experimental surveillance group, summary urine test results from the periodic testing program are available. There is no measure of treatment for the drug treatment or control groups.
  • Table of Contents

    Datasets:

    • DS1: Dataset
Temporal Coverage
  • 1984-06 / 1986-12
    Time period: 1984-06--1986-12
Geographic Coverage
  • District of Columbia
  • United States
Sampled Universe
Individual adult offenders in Washington, DC who have been arrested and interviewed by the Pretrial Services Agency.
Sampling
All adults arrested that are brought to the attention of the Pretrial Services Agency (PSA) of Washington, DC. The data exclude unfounded arrests and other arrests which were immediately disposed. Persons arrested more than once during the sampling period have multiple data records.
Collection Mode
  • Users are cautioned that some variables may contain wild codes or other unexpected values. Variables located in column positions 622-1737 are particularly subject to this condition.

Note
Funding insitution(s): United States Department of Justice. Office of Justice Programs. National Institute of Justice (83-IJ-CX-K049).
Availability
Download
This study is freely available to the general public via web download.
Alternative Identifiers
  • 9947 (Type: ICPSR Study Number)
Publications
  • Rhodes, William, Hyatt, Raymond, Scheiman, Paul. Predicting pretrial misconduct with drug tests of arrestees: Evidence from eight settings. Journal of Quantitative Criminology.12, (3), 315-348.1996.
    • ID: 10.1007/BF02354422 (DOI)
  • Visher, Christy A., Linster, Richard L.. A survival model of pretrial failure. Journal of Quantitative Criminology.6, (2), 153-184.1990.
    • ID: 10.1007/BF01065849 (DOI)
  • Toborg, M., Yezer, A.. The Efficacy of Using Urine-Test Results in Risk Classification of Arrestees. Monograph No. 6.Washington, DC: United States Department of Justice, National Institute of Justice. 1988.
  • Yezer, A., Toborg, M.. Periodic Urine-Testing as a Signaling Device for Pretrial Release Risk. Monograph No. 5.Washington, DC: United States Department of Justice, National Institute of Justice. 1988.
  • Yezer, A., Toborg, M.. Periodic Urine-testing as a signaling Device for Pretrial Relsease Risk. Monograph No. 5.Washington, DC: National Institute of Justice. 1988.
  • Toborg, M.. Background and Description of the Urine-Testing Program. Monograph No. 1.Washington, DC: United States Department of Justice, National Institute of Justice. 1987.
  • Toborg, M., Yezer, A.. Analysis of Drug Use among Arrestees. Monograph No. 4.Washington, DC: United States Department of Justice, National Institute of Justice. 1987.
  • Toborg, Mary A., Bellassai, John P., Yezer, Anthony M.J.. The Washington D.C. Urine-Testing Program for Arrestees and Defendants Awaiting Trial: A Summary of Interim Findings. Conference on Drugs and Crime: Detecting Use and Reducing Risk.. 1986.

Update Metadata: 2015-08-05 | Issue Number: 6 | Registration Date: 2015-06-15

Toborg, Mary; Yezer, Anthony; Bellassai, John (1993): Evaluation of Adult Urine Testing/Drug Use Surveillance Project in Washington, DC, 1984-1986. Version 1. Version: v1. ICPSR - Interuniversity Consortium for Political and Social Research. Dataset. https://doi.org/10.3886/ICPSR09947.v1